MAF and breast carcinoma: Furthermore, we constructed a breast cancer in situ transplantation model using MDA-MB-453 (EGFP marker) to verify the Role of CHI3L1/MAF in promoting TNBC stemness and participating in immunosuppression by exogenously administering hrCHI3L1 or/and sh-MAF-1.